Abhiram Rao is a GentiBio Board Observer and Vice President at Matrix Capital, a technology and life sciences investment firm. In addition to GentiBio, he is a Board Observer at Maze Therapeutics, AltPep and nference. Prior to Matrix, he held roles in strategy and R&D at Tempus, Illumina, and startups in biotechnology and genomics. Abhiram holds a PhD in Bioengineering from Stanford University where his research focused on early-stage drug discovery leveraging computational and high-throughput experimental technologies. He is an author on over 30 papers in journals including Science and Nature Genetics.
Abhiram Rao, PhD
Vice President, Matrix Capital Management, Board Observer